Taylor Gwin, MD
Vascular Surgery · Baton Rouge, LANPI 1093974099
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $5,569 of the $6,544 with a category attached, or 85.1%. It is spread thinly across 36 manufacturers, the largest accounting for just 23.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,717 and has fallen 81.9% since, to $311 in 2025.
Across 162 payments — averaging $40.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bard Peripheral Vascular, Inc.$2K
- W. L. Gore & Associates, Inc.$1K
- Endologix LLC$822
- Inari Medical, Inc.$297
- Smith+Nephew$249
- Boston Scientific$242
- plus $2K from 30 others
What the payments were for
- Travel & lodging$93614%
- Food & beverage$5,56985%
- Education$391%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bard Peripheral Vascular, Inc. | 29 | $1,553 |
| W. L. Gore & Associates, Inc. | 20 | $1,445 |
| Endologix LLC | 3 | $822 |
| Inari Medical, Inc. | 5 | $297 |
| Smith+Nephew | 15 | $249 |
| Boston Scientific | 15 | $242 |
| Johnson & Johnson(2 entities) | 13 | $217 |
| Shockwave Medical, Inc | 2 | $157 |
| Atricure, Inc. | 1 | $122 |
| Avinger Inc. | 2 | $121 |
| Tactile Systems Technology Inc | 5 | $101 |
| Kerecis Limited | 4 | $99 |
| Trisalus Life Sciences, Inc. | 4 | $88 |
| AstraZeneca | 5 | $88 |
| Fresenius USA Marketing, Inc. | 5 | $85 |
| Medtronic | 4 | $83 |
| Penumbra, Inc. | 1 | $81 |
| Cardiovascular Systems Inc. | 1 | $78 |
| Mimedx Group, Inc. | 3 | $70 |
| GSK | 2 | $57 |
| EKOS Corporation | 4 | $52 |
| Humacyte Global, Inc. | 2 | $45 |
| Sirtex Medical Inc | 1 | $41 |
| Aroa Biosurgery Incorporated | 1 | $39 |
| Convatec Inc. | 1 | $35 |
| Angiodynamics, Inc. | 1 | $35 |
| Silk Road Medical, Inc. | 2 | $34 |
| Sanara Medtech Inc. | 1 | $29 |
| Artivion, Inc. | 3 | $28 |
| Qapel Medical Inc | 1 | $26 |
| Bolton Medical Inc | 1 | $24 |
| Catheter Precision, Inc. FKA Ra Medical Systems, Inc. | 1 | $23 |
| Argon Medical Devices, Inc. | 1 | $21 |
| Terumo Medical Corporation | 1 | $19 |
| Abbott | 1 | $18 |
| Getinge USA Sales, LLC | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Ovation$807
- GORE TAG Thoracic Endoprosthesis$335
- AFX$318
- GORE VIABAHN VBX Balloon Expandable Endo$258
- GORE VIABAHN Endoprosthesis with Heparin$199
- GORE TAG Conformable Thoracic Endoprosthesis$142
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$142
- ATRICURE CRYOICE CRYOSPHERE CRYOABLATION SYSTEM$122
- PANTHERIS$100
How this compares
$6,544 in reported general payments places this provider in the 55th percentile of 65 vascular surgery providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 36 | $34,465 |
| EliquisApixaban | 29 | $19,736 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 133 | $1,670 |
| ClopidogrelClopidogrel Bisulfate | 129 | $797 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 79 | $591 |
| Nifedipine ErNifedipine | 14 | $320 |
| Cilostazol | 24 | $226 |
| Gabapentin | 28 | $205 |
| Duloxetine Hcl | 19 | $178 |
| Doxycycline Hyclate | 11 | $144 |
| Warfarin Sodium | 23 | $95 |
| Amitriptyline Hcl | 12 | $54 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $217 | $34,46536 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 65 vascular surgery providers in Louisiana.
Other vascular surgery in Baton Rouge
- Michael Conners IiiBaton Rouge$70K
- James CravenBaton Rouge$65K
- Marvin WeaverBaton Rouge$58K
- London GuidryBaton Rouge$25K
- Paul DavisBaton Rouge$18K
- Gulrez MahmoodBaton Rouge$9K
- Matthew AbateBaton Rouge$9K
- Wajeeh IrfanBaton Rouge$7K
- Madeline DillsBaton Rouge$5K
- James McNeilBaton Rouge$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.